Browse: Companies | People | Financial Organizations
Home > Financial Organizations > OrbiMed Advisors

General Information

Websiteorbimed.com
Phone1-212-739-6400
Email
Employees
Founded1989

Funds

Offices

New York, USA
767 Third Avenue
30th Floor
New York, NY, 10017
USA

People

Chief Financial Officer
Controller

Tags

OrbiMed Advisors

OrbiMed is ahealthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed’s investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.

Milestones

Investments

Company Date Round Size Participants
PharmAbcine 9/09Series A$6M4
Complete Genomics 8/09Series D$45M6
Enobia Pharma 8/09Series C$50M4
Aragon Pharmaceuticals 5/09Series A$8M2
Cerapedics 4/09Series B$15M2
Singulex 1/09Series E$19M3
ARYx Therapeutics 11/08Unattributed$21.6M3
Biolex Therapeutics 10/08Series D$60M12
Innovative Spinal Technologies 9/08Series C$18M2
Glaukos 8/08Series D$35M7
InteKrin 8/08Series C$18.5M7
Enobia Pharma 8/07Series BC$40.1M4
Singulex 6/07Series D$19M3
Sientra 4/07Series B$85M3
ChemoCentryx 3/07Series D$29.8M5
ChemoCentryx 6/04Unattributed$33M5

Videos

Sources

  1. PharmAbcine Closes USD $6 Million Series A Financing (bio-medicine.org) [edit]
  2. Complete Genomics bags $45M round for sequencing (fiercebiotech.com) [edit]
  3. Enobia Raises US$50M from Current Investors in Series C Financing (enobia.com) [edit]
  4. Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]
  5. CeraPedics, Inc. Raises $15 Million (devicespace.com) [edit]
  6. Singulex Closes $19 Million Financing Round (bio-medicine.org) [edit]
  7. ARYx Therapeutics Inc. Announces $21.6 Million Private Placement (investors.aryx.com) [edit]
  8. Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C (mitsuiventures.com) [edit]
  9. Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says (xconomy.com) [edit]
  10. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
  11. InteKrin raises $18.5M for continued work on diabetes drug (deals.venturebeat.com) [edit]
  12. enobia.com [edit]
  13. Biomarker-diagnostics developer Singulex validates $19M (venturebeat.com) [edit]
  14. Sientra, device maker for plastic surgery, raises $85M (deals.venturebeat.com) [edit]
  15. ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com) [edit]
  16. ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com) [edit]
Edit This Page
Last Edited 9/29/09

Revision History RSS Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy